Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanoma-associated antigen family A5 pseudogene (MAGEA5P) is a member of the MAGEA gene family located on chromosome Xq28. Although listed alongside protein-coding cancer/testis antigens, MAGEA5P is classified as a pseudogene, meaning it does not produce a functional protein product. There is ambiguity in some databases and literature, with some records describing a truncated protein sequence; however, the current consensus and annotation indicate this locus is non-functional and not expressed as a protein in normal or tumor tissues[1][2][3]. As a pseudogene, MAGEA5P does not serve as a direct therapeutic target nor is it a relevant biomarker or functional participant in disease pathways. The MAGE family (especially other MAGE-A members) is strongly implicated in cancer immunity and cell regulation, but these functions are not attributed to MAGEA5P. Context and rationale: MAGEA5P is explicitly annotated as a *pseudogene*, meaning it does not encode a functional protein (though some sources historically listed a truncated protein hypothetically)[1]. No evidence exists of translation into a functional protein, no known biological or pathological functions, and no drugs known to interact with the gene product. Its family (MAGE-A) is highly relevant in cancer/testis antigens and cancer immunity, but not this specific pseudogene. “is_incorrect” is set to true because it is not a valid therapeutic target and is sometimes mistakenly treated as protein-coding or conflated with the functional MAGEA5 gene. If you are seeking a cancer/testis antigen target, MAGEA5 (the functional gene, not the pseudogene), or other MAGE-A family members such as MAGEA3 or MAGEA4, may be more relevant. Key facts supported by sources: – MAGEA5P is a pseudogene, does not code for a protein, and has no direct target function[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoma-associated antigen family A5 pseudogene (MAGEA5P).